Cancer stem cells and tumor-associated macrophages: Interactions and therapeutic opportunities

被引:1
作者
Yuan, Haitao [1 ]
Qiu, Yun [1 ]
Mei, Zijie [1 ]
Liu, Jiaqing [1 ]
Wang, Lingna [1 ]
Zhang, Kaiqing [1 ]
Liu, Huicong [1 ]
Zhu, Fangfang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer stem cells; Tumor-associated macrophages; Cancer stemness maintenance; Tumor microenvironment; Macrophage polarization; Chemokine/cytokine signaling; Exosomal miRNAs; CAR-Macrophage therapy; Immune checkpoint blockade; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE BREAST-CANCER; ACUTE MYELOID-LEUKEMIA; DUAL ROLE; PROMOTES; POLARIZATION; PROGRESSION; CARCINOMA; INDUCE; HETEROGENEITY;
D O I
10.1016/j.canlet.2025.217737
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer stem cells (CSCs) depend on the tumor microenvironment (TME) to sustain their stem-like properties by recruiting monocytes and reprogramming them into tumor-associated macrophages (TAMs), which in turn promote tumor progression. This review explores CSC-TAM interactions, emphasizing how CSCs drive monocyte recruitment and TAM polarization. We discuss how TAMs enhance CSC stemness and niche maintenance through chemokines, cytokines, exosome-mediated miRNA transfer, direct interactions, and extracellular matrix (ECM) remodeling. Furthermore, we examine therapeutic strategies targeting TAMs, including inhibiting TAM differentiation, reprogramming TAM polarization, and leveraging immune checkpoint blockade and CAR-macrophage immunotherapy to improve cancer treatment outcomes.
引用
收藏
页数:12
相关论文
共 126 条
[1]  
Abdin S.M., 2023, J. Immunother. Cancer, V11, DOI 10.1136
[2]   Tumor macrophages are pivotal constructors of tumor collagenous matrix [J].
Afik, Ran ;
Zigmond, Ehud ;
Vugman, Milena ;
Klepfish, Mordehay ;
Shimshoni, Elee ;
Pasmanik-Chor, Metsada ;
Shenoy, Anjana ;
Bassat, Elad ;
Halpern, Zamir ;
Geiger, Tamar ;
Sagi, Irit ;
Varol, Chen .
JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (11) :2315-2331
[3]  
[Anonymous], 2023, Nat. Rev. Cancer, V23, P238, DOI [10.1038/s41568-022-00547-1, DOI 10.1038/S41568-022-00547-1]
[4]   Developmental control of macrophage function [J].
Bonnardel, Johnny ;
Guilliams, Martin .
CURRENT OPINION IN IMMUNOLOGY, 2018, 50 :64-74
[5]   Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J].
Bonnet, D ;
Dick, JE .
NATURE MEDICINE, 1997, 3 (07) :730-737
[6]   Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression [J].
Cao, Xu ;
Wang, Yingyu ;
Zhang, Wencan ;
Zhong, Xiancai ;
Gunes, E. Gulsen ;
Dang, Jessica ;
Wang, Jinhui ;
Epstein, Alan L. ;
Querfeld, Christiane ;
Sun, Zuoming ;
Rosen, Steven T. ;
Feng, Mingye .
BLOOD, 2022, 139 (22) :3290-3302
[7]   Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells [J].
Casanova-Acebes, Maria ;
Dalla, Erica ;
Leader, Andrew M. ;
LeBerichel, Jessica ;
Nikolic, Jovan ;
Morales, Blanca M. ;
Brown, Markus ;
Chang, Christie ;
Troncoso, Leanna ;
Chen, Steven T. ;
Sastre-Perona, Ana ;
Park, Matthew D. ;
Tabachnikova, Alexandra ;
Dhainaut, Maxime ;
Hamon, Pauline ;
Maier, Barbara ;
Sawai, Catherine M. ;
Agullo-Pascual, Esperanza ;
Schober, Markus ;
Brown, Brian D. ;
Reizis, Boris ;
Marron, Thomas ;
Kenigsberg, Ephraim ;
Moussion, Christine ;
Benaroch, Philippe ;
Aguirre-Ghiso, Julio A. ;
Merad, Miriam .
NATURE, 2021, 595 (7868) :578-+
[8]   Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets [J].
Cassetta, Luca ;
Fragkogianni, Stamatina ;
Sims, Andrew H. ;
Swierczak, Agnieszka ;
Forrester, Lesley M. ;
Zhang, Hui ;
Soong, Daniel Y. H. ;
Cotechini, Tiziana ;
Anur, Pavane ;
Lin, Elaine Y. ;
Fidanza, Antonella ;
Lopez-Yrigoyen, Martha ;
Millar, Michael R. ;
Urman, Alexandra ;
Ai, Zhichao ;
Spellman, Paul T. ;
Hwang, E. Shelley ;
Dixon, J. Michael ;
Wiechmann, Lisa ;
Coussens, Lisa M. ;
Smith, Harriet O. ;
Pollard, Jeffrey W. .
CANCER CELL, 2019, 35 (04) :588-+
[9]   Targeting macrophages: therapeutic approaches in cancer [J].
Cassetta, Luca ;
Pollard, Jeffrey W. .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904
[10]   Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy [J].
Cen, Yi ;
Chen, Ying ;
Li, Xinxuan ;
Chen, Xiayun ;
Yu, Baixue ;
Yan, Mengyi ;
Yan, Ni ;
Cheng, Hong ;
Li, Shiying .
BIOMATERIALS, 2024, 308